相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1
Etsuko Iio et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan
Norio Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment
Goki Suda et al.
HEPATOLOGY RESEARCH (2017)
EASL Recommendations on Treatment of Hepatitis C 2016
JOURNAL OF HEPATOLOGY (2017)
Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens
Norio Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
Eleanor M. Wilson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Retreatment With Sofosbuvir and Simeprevir of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed a Daclatasvir-Containing Regimen
Christophe Hezode et al.
HEPATOLOGY (2016)
Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism
Yoshihito Uchida et al.
HEPATOLOGY RESEARCH (2016)
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection
Jun Ito et al.
HEPATOLOGY RESEARCH (2016)
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
Goki Suda et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice
Yugo Kai et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami et al.
LANCET INFECTIOUS DISEASES (2015)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions
Goki Suda et al.
HEPATOLOGY RESEARCH (2015)
In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir
Jacques Friborg et al.
INFECTIOUS DISEASES AND THERAPY (2015)
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection
Hiromitsu Kumada et al.
HEPATOLOGY (2014)
Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885
Kelly A. Wong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial
Anuoluwapo Osinusi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
Yoshiyuki Suzuki et al.
JOURNAL OF HEPATOLOGY (2013)
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Edward J. Gane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy-A Genome-Wide Study of Japanese HCV Virus Patients
Hidenori Ochi et al.
GASTROENTEROLOGY (2010)
The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors
Matthew F. McCown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
A high-throughput SNP typing system for genome-wide association studies
Y Ohnishi et al.
JOURNAL OF HUMAN GENETICS (2001)
分享论文
